FIELD: food industry; chemistry; pharmaceutics.
SUBSTANCE: invention relates to the field of food and chemical-pharmaceutical industry and concerns a set of biologically active substances complexes for appetite control and weight normalization. Kit comprises three products for oral administration. First said product is a complex of biologically active substances in the form of a single dosage form containing thylakoids and a dry extract of bitter orange fruits, standardized by p-Synephrine. Second product is a soft capsule containing ginger oil, olive oil and limonene. Third specified product in the form of a single dosage form contains dry extract of red pepper standardized by capsaicin. Method for controlling appetite and normalizing body weight involves oral intake of kit 2 or 3 times a day, wherein the first and second set products are taken simultaneously before or during meals, and after meal the third product of the kit is taken.
EFFECT: invention promotes appetite reduction, a long period of satiety after meals, reduced sweet cravings, as well as facilitates monitoring of calorie content, tones up the body stimulating physical activity.
3 cl, 4 ex
Title | Year | Author | Number |
---|---|---|---|
BIOLOGICALLY ACTIVE COMPOSITION IN FORM OF LOZENGE | 2015 |
|
RU2613180C2 |
ORALLY DISINTEGRATING TABLET OF DEHYDROEPIANDROSTERONE AND/OR COMBINATION OF DEHYDROEPIANDROSTERONE AND L-THEANINE | 2014 |
|
RU2557960C1 |
METHOD FOR PRODUCTION OF CLOZAPINE PHARMACEUTICAL COMPOSITION IN FORM OF TABLETS AND PHARMACEUTICAL COMPOSITION | 2010 |
|
RU2441651C1 |
PHARMACEUTICAL COMPOSITION OF PROLONGED ACTION FOR CORRECTION OF PSYCHOSOMATIC MANIFESTATIONS | 2009 |
|
RU2424807C2 |
PHARMACEUTICAL COMPOSITION IN FORM OF HARD PERORAL DRUG FOR TREATMENT OF GASTROINTESTINAL TRACT DISEASES | 2009 |
|
RU2418576C2 |
ORALLY DISPERSIBLE TABLET OF DEHYDROEPIANDROSTERONE | 2014 |
|
RU2545812C1 |
PHARMACEUTICAL COMPOSITION OF PROLONGED ACTION BASED ON CLOZAPINE OF PERORAL INTRODUCTION | 2009 |
|
RU2414903C1 |
AGENT FOR TREATING FUNCTIONAL GASTROINTESTINAL DISEASES | 2020 |
|
RU2740750C1 |
NADH COMPOSITION HAVING ANTIOXIDANT PROPERTIES | 2014 |
|
RU2545920C1 |
DRUG FOR GASTROINTESTINAL TRACT AND HEPATOBILIARY SYSTEM DISEASES TREATMENT AND PREVENTING RECRUDESCENCES | 2017 |
|
RU2651711C1 |
Authors
Dates
2020-06-03—Published
2019-10-17—Filed